The global IUD market size is expected to value USD 2034 million by 2026 from USD 1610 million in 2021, growing at a CAGR of 4.78% during the forecast period.
The intrauterine contraceptive is a medical device used to insert into the uterus to avoid the chances of conceiving. The device is used as an emergency contraceptive post to the unwanted sex—two contraceptive devices like copper intrauterine contraceptive devices and hormonal intrauterine contraceptive devices. The medical device is a T-shaped device inserted into the uterus to prevent conception. IUCDs are generally a form of long-acting reversible contraceptives (LARC) assisting in birth control for an enlarged period. As per an article published by a patient, a web-based health information platform, Intrauterine contraceptives devices are cost-effective as 1 to 2 out of every 100 women will conceive after 5 years of using them. Couples or women who don't use IUCDs create and count may reach 80 out of 100 within a year. The demand for these intra-uterine contraceptive devices is significantly growing due to the research and development activities and innovative product launches.
The rise in awareness over the availability of these devices through campaigns and digital advertisements is majorly driving the growth of the IUD Market.
The Intrauterine Devices are small T-shaped devices placed in women’s uterus to prevent pregnancy. Hormone-based copper and hormone-based IUDs are two popular devices in the market. Some of the drivers that propel the Intrauterine Contraceptive Devices market are long-lasting, very good for preventing pregnancy, easy to use and maintain, and cost-effective. Initiative steps by the government in promoting the benefits with the use of IUDs greatly influence the demand of the market.
Additionally, the rise in the number of working-class women across the globe and advancements in the technology of IUDs, increasing the commonness of sexually transmitted diseases, and government funds are some of the other factors fueling the growth of the Global IUD Market.
The emergence of advanced technology and the launch of innovative products create growth opportunities for the market. Even in undeveloped countries, raising awareness of these devices is solely to fuel the market's demand. Also, ongoing research on developing new products is escalating the growth rate of the Intrauterine Contraceptive Devices market.
Factors that are hampering the market growth are inadequate importance during conception consultations, lack of proper knowledge over the use of the devices in rural areas, pelvic inflammatory infection, infertility issues, ectopic pregnancy, and limited access for conception. Factors like heavy bleeding, irregular bleeding, and cramps are the factors that are likely to sluggish the global intrauterine contraceptive devices market growth.
The shortage of skilled people in healthcare centers is a key challenging factor for the global intrauterine contraceptive devices market players.
Impact of COVID-19 on the global intrauterine contraceptive devices market:
The novel coronavirus has originated in Wuhan, China, and has spread to almost every corner of the world. The World Health Organization (WHO) declared an emergency public health issue in March 2020. The COVID 19 pandemic crisis has created a negative impact on contraceptives and the sexual health market. The primary disturbance is created due to the availability of contraceptives among the people—the decrease in the manufacturing and supply quantities of birth control pills worldwide. The incompetence of millions of men and women across the country to access contraceptives during the lockdown period is foreseen to significantly impact reproductive health indicators, including both maternal and infant mortality rates. The inadequate access to contraceptives over the best scenario case is to exhibit an extra 1.9 million unwanted pregnancies. Worldwide, 50% of pregnancies are unwanted. The intrauterine contraceptive devices market is expected to have significant growth in the coming years.
Market Size Available
2020 to 2026
2021 to 2026
By Product Type and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, APAC, Latin America, Middle East & Africa
Market Leaders Profiled
Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc, Bayer, Teva Pharmaceutical, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd, Okamato Industries, Inc, Pfizer.
This research report on the global intrauterine contraceptive devices market has been segmented and sub-segmented based on the product type and region.
Intrauterine Contraceptive Devices Market – By Product Type:
Based on product type, the Hormonal Intrauterine Contraceptive Devices segment is estimated to have the highest market share since hormonal Intrauterine Contraceptive Devices have fewer complications and risks non-hormonal Intrauterine Contraceptive Devices.
Intrauterine Contraceptive Devices Market – By Region:
Geographically, North America is expected to have the largest share in the global intrauterine contraceptive devices market value. The U.S. is one ruling with the largest shares of the market in this region. A growing number of young women are surging the demand of the market in this region.
Europe is expected to hold the second-largest share value of the IUD market. In this region, the factors driving this region are the rising number of sexually transmitted diseases and growing disposable income in urban areas.
Asia-Pacific is to hold the highest CAGR in the forecast period. India and China are significant countries contributing the highest shares to the market. Growing support from government and non-government organizations through investments in the healthcare center is leveraging the market's demand.
KEY MARKET PLAYERS:
Some of the prominent companies leading the global intrauterine contraceptive devices market profiled in this report are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc., Bayer, Teva Pharmaceutical, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd., Okamato Industries, Inc., and Pfizer.
RECENT MARKET DEVELOPMENTS:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Hormonal Intrauterine Devices
5.1.2 Copper Intrauterine Devices
6. Geographical Analysis
6.1 North America
6.1.2 United States
6.3.5 South Korea
6.4 Latin America
6.4.4 Rest of Latin America
6.5 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Agile Therapeutics
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Actavis PLC
8.3 ANI Pharmaceuticals
8.5 Teva Pharmaceutical
8.6 Besins HealthCare
8.7 Brecuro Medical
8.8 Effik International
8.10 HLL Lifecare
8.11 HRA Pharma
8.12 Lupin Pharmaceuticals
8.13 Okamato Industries
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market outlook and Investment oppurtunities
a) List of Tables
b) List of Figures